Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anatomy of the Eyeball01:20

Anatomy of the Eyeball

10.0K
The eye is a spherical, hollow structure composed of three tissue layers. The outer layer — the fibrous tunic, comprises the sclera — a white structure — and the cornea, which is transparent. The sclera encompasses some of the ocular surface, most of which is not visible. However, the 'white of the eye' is distinctively visible in humans compared to other species. The cornea, a clear covering at the front of the eye, enables light penetration. The eye's middle...
10.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Six-Month Real-World Data in Macular Edema Due to Retinal Vein Occlusion Treated with Faricimab: Swiss Retina Research Network Report.

Ophthalmology and therapy·2026
Same author

Parafoveal Dark Adaptation in Early and Intermediate Age-Related Macular Degeneration.

Investigative ophthalmology & visual science·2026
Same author

Monotherapy with PHMB 0.08% as "Switch Treatment" in Complex Cases of Acanthamoeba Keratitis: A Report of Two Cases.

Case reports in ophthalmology·2026
Same author

Microvascular Properties of Dissociated Optic Nerve Fiber Layer (DONFL) After Internal Limiting Membrane Peeling.

Investigative ophthalmology & visual science·2026
Same author

The Therapeutic Approach and Mechanism of Action of Insulin Eye Drops for the Treatment of Neurotrophic Keratitis.

Drug design, development and therapy·2026
Same author

The optical coherence tomography and microperimetry biomarker evaluation in patients with geographic atrophy (OMEGA) study: Geographic atrophy progression in fundus autofluorescence - OMEGA report 3.

Acta ophthalmologica·2026
Same journal

Corneal Neurotisation in Neurotrophic Keratopathy: A Retrospective Analysis of Functional Outcomes and Clinical Courses.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Evaluating the Long-term Success and Safety of Canaloplasty in Glaucoma Patients.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Imbalanced Trace Elements as Risk Factors in the Pathogenesis of Glaucoma.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Malnutrition as a Risk Factor for Cerebral and Glaucomatous Neurodegeneration - Mechanisms and Therapeutic Strategies.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Impact of Wearing a Face Mask on the Reliability of Standard Automated Perimetry in Glaucoma Patients and Suspects: a Retrospective Longitudinal Study.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

[Siderotic Cataract Eight Months After Intralenticular Metallic Foreign Body: A Case Report and Surgical Management].

Klinische Monatsblatter fur Augenheilkunde·2026
See all related articles

Related Experiment Video

Updated: Feb 19, 2026

A Murine Model of Ischemic Retinal Injury Induced by Transient Bilateral Common Carotid Artery Occlusion
05:20

A Murine Model of Ischemic Retinal Injury Induced by Transient Bilateral Common Carotid Artery Occlusion

Published on: November 12, 2020

8.2K

[The retinal artery occlusion].

Nicolas Feltgen, Kristina Pfau, Isabel Stasik

    Klinische Monatsblatter Fur Augenheilkunde
    |February 17, 2026
    PubMed
    Summary
    This summary is machine-generated.

    Retinal artery occlusion (RAO) is a severe vision-threatening condition. While intravenous fibrinolysis shows promise, its effectiveness and optimal time window for RAO require further clinical trials for this emergency condition.

    More Related Videos

    In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
    07:35

    In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

    Published on: April 21, 2022

    2.7K
    Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography
    07:23

    Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography

    Published on: March 26, 2020

    8.7K

    Related Experiment Videos

    Last Updated: Feb 19, 2026

    A Murine Model of Ischemic Retinal Injury Induced by Transient Bilateral Common Carotid Artery Occlusion
    05:20

    A Murine Model of Ischemic Retinal Injury Induced by Transient Bilateral Common Carotid Artery Occlusion

    Published on: November 12, 2020

    8.2K
    In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
    07:35

    In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

    Published on: April 21, 2022

    2.7K
    Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography
    07:23

    Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography

    Published on: March 26, 2020

    8.7K

    Area of Science:

    • Ophthalmology
    • Neurology
    • Vascular Medicine

    Background:

    • Retinal artery occlusion (RAO) is a critical ophthalmic emergency causing sudden, unilateral vision loss.
    • Currently, no established causal therapy exists for RAO, leading to potential blindness.
    • Giant cell arteritis (GCA) is a rare but crucial underlying cause that must be considered.

    Purpose of the Study:

    • To review the current understanding and management of Retinal Artery Occlusion (RAO).
    • To highlight the potential of intravenous fibrinolysis as a treatment for RAO.
    • To emphasize the urgency and need for prompt medical evaluation in suspected RAO cases.

    Main Methods:

    • Literature review of existing studies on RAO.
    • Analysis of current treatment strategies, including emerging therapies like fibrinolysis.
    • Discussion of diagnostic considerations, particularly for underlying conditions like GCA.

    Main Results:

    • RAO leads to significant vision impairment and blindness.
    • Intravenous fibrinolysis is under investigation, showing potential but lacking proven benefits and a defined time window.
    • Emergency neurological admission is advised due to risks of further embolic events.

    Conclusions:

    • RAO necessitates urgent management, with time being critical for vision preservation.
    • Intravenous fibrinolysis represents a promising, yet unproven, therapeutic avenue for RAO.
    • Systemic conditions like GCA must be ruled out in RAO patients.